Word

AVERITAS PHARMA

Status

Pending

Status Code

731

Status Date

Thursday, May 2, 2024

Serial Number

97381068

Mark Type

4

Filing Date

Tuesday, April 26, 2022

Published for Opposition

Tuesday, March 28, 2023

Trademark Owner History

Averitas Pharma, Inc. - Owner At Publication

Classifications

41 Conducting of training courses in the field of medicine and pharmaceuticals; issuance and publication of books, journals and other communication media in print and electronic form, namely, publishing and issuing of books, journals and scientific papers in the field of medicine and pharmaceuticals, especially for pharmaceutical companies, pharmacists, physicians, patients, health insurance companies and their professional associations

5 Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of inflammation and gout; vaccines; sanitary preparations for medical purposes; dietetic substances to support nutritional balance and to treat deficiencies, namely, vitamins, mineral supplements, and probiotic preparations adapted for medical use; Wound dressings; surgical dressings; bandages, medical adhesive patches and medical adhesive tapes for dressings; medical adhesives to bind wounds; bandages, medical adhesive patches, medical adhesive tapes and medical adhesives to close skin wounds, incisions and cuts

42 Scientific and technological services and research in the medical and pharmaceutical field, namely, pharmaceutical product development, product development of medical devices, development of healthcare software, development of healthcare informatics services and scientific study and research services in the fields of medicine and the prevention, treatment and management of illnesses, diseases and disorders

"PHARMA"

Trademark Events

Feb 14, 2023

Assigned To Examiner

Apr 29, 2022

New Application Entered

May 2, 2022

New Application Office Supplied Data Entered

Feb 21, 2023

Examiners Amendment -Written

Feb 21, 2023

Examiners Amendment E-Mailed

Feb 21, 2023

Notification Of Examiners Amendment E-Mailed

Feb 21, 2023

Examiner's Amendment Entered

Feb 21, 2023

Approved For Pub - Principal Register

Mar 8, 2023

Notification Of Notice Of Publication E-Mailed

Mar 28, 2023

Published For Opposition

Mar 28, 2023

Official Gazette Publication Confirmation E-Mailed

May 23, 2023

Noa E-Mailed - Sou Required From Applicant

Nov 20, 2023

Sou Teas Extension Received

Nov 20, 2023

Sou Extension 1 Granted

Nov 20, 2023

Sou Extension 1 Filed

Nov 22, 2023

Notice Of Approval Of Extension Request E-Mailed

May 2, 2024

Teas Request To Divide Received

May 2, 2024

Sou Extension 2 Granted

May 2, 2024

Sou Teas Extension Received

May 2, 2024

Sou Extension 2 Filed

May 2, 2024

Teas Statement Of Use Received

May 3, 2024

Notice Of Approval Of Extension Request E-Mailed

Jun 10, 2024

Case Assigned To Intent To Use Paralegal

Jun 11, 2024

Itu Office Action Issued For Divisional Request